Loading…
Diabetic Vision Loss and Blindness Prevention Act of 2019
Legislative Progress
Introduced
November 22, 2019
Latest Action
November 25, 2019
Primary Sponsor
Terri A. SewellDemocratic(AL)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
63pct
3d open
vs 9,062 other HR bills in the 116th — cohort avg 39d
Diabetic Vision Loss and Blindness Prevention Act of 2019 This bill provides for Medicare coverage of digital retinal imaging with remote interpretation, which is used to detect or assess a certain diabetic eye condition. The Centers for Medicare & Medicaid Services must ensure that beneficiaries who receive such services are also given information about available diabetes self-management training and that such training includes information about the importance of annual eye exams.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (5)
2021 · first_quarter · Medicare/Medicaid
Medicare coverage for medical technology. H.R. 5254, the Diabetic Vision Loss and Blindness Prevention Act.
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2021 · first_quarter · Health Issues
Medicare coverage for medical technology. H.R. 5254, the Diabetic Vision Loss and Blindness Prevention Act.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · fourth_quarter · Health Issues
H.R.3630, No Surprises Act of 2019. H.R.3762, Dental and Optometric Care Access Act. H.R.5254, Diabetic Vision Loss and Blindness Prevention Act of 2019. S. 4894, DOC Access Act of 2019.
Client expense: $400,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
Technology research; Telemedicine and connected care; Remote patient monitoring; Implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA reform; Sepsis funding and education; Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).; COVID-19 health care legislative and regulatory implementation and funding issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748) and the HEROES Act (H.R. 6800), Consolidated Appropriations Act, 2021 (H.R. 133)
Client expense: Not reported · Firm income: $70,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of
2020 · fourth_quarter · Medicare/Medicaid
Technology research; Telemedicine and connected care; Remote patient monitoring; Implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA reform; Sepsis funding and education; Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).; COVID-19 health care legislative and regulatory implementation and funding issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748) and the HEROES Act (H.R. 6800), Consolidated Appropriations Act, 2021 (H.R. 133)
Client expense: Not reported · Firm income: $70,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of
2020 · fourth_quarter · Medicare/Medicaid
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act 2020 (H.R. 6074),the CARES Act (S. 3548/H.R. 748); and the HEROES Act (H.R. 6800); Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the implementation of The Medicare Access and CHIP Reauthorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA Reform; Sepsis funding and education; Further Consolidated Appropriations Act of 2020 (H.R. 1865), Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R. 5254)
Client expense: $230,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of
2020 · fourth_quarter · Health Issues
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748);and the Heroes Act (H.R.6800) Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the implementation of The Medicare Access and CHIP Reauthorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA Reform; Sepsis funding and education; Further Consolidated Appropriations Act of 2020 (H.R. 1865), Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R. 5254)
Client expense: $230,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of
2020 · fourth_quarter · Medicare/Medicaid
Medicare coverage for medical technology. H.R. 5254, the Diabetic Vision Loss and Blindness Prevention Act.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Vice President of the U.S.
2020 · fourth_quarter · Health Issues
Medicare coverage for medical technology. H.R. 5254, the Diabetic Vision Loss and Blindness Prevention Act.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Vice President of the U.S.
2020 · third_quarter · Health Issues
S. 1895 - Lower Health Care Costs Act H.R. 2668 - Special Diabetes Program Reauthorization Act of 2019 H.R. 2680 - Special Diabetes Program for Indians Reauthorization Act of 2019 S. 3937 - Special Diabetes Program for Indians Reauthorization Act of 2020 H.R. 2328 - Reauthorizing and Extending Americas Community Health Act (REACH Act) S. 2543 - The Prescription Drug Pricing Reduction Act of 2019 S. 2199, H.R. 4906 - Insulin Price Reduction Act S. 2004, H.R. 4010 -- Emergency Access to Insulin Act of 2019 H.R. 3 - Lower Drug Costs Now Act of 2019 H.R. 5749 - Affordable Insulin for All Act S. 2855, H.R. 5691 - Insulin Affordability Data Collection Act H.R. 19, S. 3129 - Lower Costs, More Cures Act of 2019 Issues and legislation related to drug pricing, specifically as it relates to insulin. Issues and legislation related to a passthrough of any/all savings to beneficiaries using insulin in Medicare Part D. Issues and legislation related to providing flexibility in the split of a deductible between devices and prescription drugs. Issues related to the importance of preserving health insurance protections for individuals with pre-existing conditions. H.R. 5254 - Diabetic Vision Loss and Blindness Prevention Act of 2019 Issues related to providing (during the COVID-19 emergency period) and preserving (after the COVID-19 emergency period) telehealth/telemedicine flexibilities for individuals with type 1 diabetes. S. 4315/H.R. 6666 - COVID-19 Testing, Reaching, And Contacting Everyone Act (TRACE) Act
Client expense: $70,000 · Firm income: Not reported
2020 · third_quarter · Health Issues
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Technology research; Telemedicine and connected care; Remote patient monitoring; Implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).; COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748); and the HEROES Act (H.R. 6800)Technology research.
Client expense: Not reported · Firm income: $70,000
2020 · third_quarter · Medicare/Medicaid
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the COVID-19 health care issues issues within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); Telemedicine and connected care; Remote patient monitoring; Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); The implementation of the Medicare Access and CHIP reauthorization Act (H.R. 2); Safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).; COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the COVID-19 health care issues issues within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748); the HEROES Act (H.R. 6800)
Client expense: Not reported · Firm income: $70,000
2020 · third_quarter · Health Issues
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act 2020 (H.R. 6704), the CARES Act (S. 3548/H.R. 748);and the Heroes Act (H.R.6800) Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the implementation of The Medicare Access and CHIP Reauthorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA Reform; Sepsis funding and education; Further Consolidated Appropriations Act of 2020 (H.R. 1865), Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R. 5254),
Client expense: $220,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
2020 · third_quarter · Medicare/Medicaid
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act 2020 (H.R. 6704),the CARES Act (S. 3548/H.R. 748); and the HEROES Act (H.R. 6800); Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the implementation of The Medicare Access and CHIP Reauthorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA Reform; Sepsis funding and education; Further Consolidated Appropriations Act of 2020 (H.R. 1865), Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R. 5254)
Client expense: $220,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
2020 · third_quarter · Medicare/Medicaid
Medicare coverage for medical technology. H.R. 5254, the Diabetic Vision Loss and Blindness Prevention Act.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Vice President of the U.S.
2020 · third_quarter · Health Issues
Medicare coverage for medical technology. H.R. 5254, the Diabetic Vision Loss and Blindness Prevention Act.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Vice President of the U.S.
2020 · third_quarter · Health Issues
H.R.3630, No Surprises Act of 2019. H.R.3762, Dental and Optometric Care Access Act. H.R.5254, Diabetic Vision Loss and Blindness Prevention Act of 2019.
Client expense: $300,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Health Issues
S. 1895 - Lower Health Care Costs Act H.R. 2668 - Special Diabetes Program Reauthorization Act of 2019 H.R. 2680 - Special Diabetes Program for Indians Reauthorization Act of 2019 S. 3937 - Special Diabetes Program for Indians Reauthorization Act of 2020 H.R. 2328 - Reauthorizing and Extending Americas Community Health Act (REACH Act) S. 2543 - The Prescription Drug Pricing Reduction Act of 2019 S. 2199, H.R. 4906 - Insulin Price Reduction Act S. 2004, H.R. 4010 -- Emergency Access to Insulin Act of 2019 H.R. 3 - Lower Drug Costs Now Act of 2019 H.R. 5749 - Affordable Insulin for All Act S. 2855, H.R. 5691 - Insulin Affordability Data Collection Act H.R. 19, S. 3129 - Lower Costs, More Cures Act of 2019 Issues and legislation related to drug pricing, specifically as it relates to insulin. Issues and legislation related to a passthrough of any/all savings to beneficiaries using insulin in Medicare Part D. Issues and legislation related to providing flexibility in the split of a deductible between devices and prescription drugs. Issues related to the importance of preserving health insurance protections for individuals with pre-existing conditions. H.R. 5254 - Diabetic Vision Loss and Blindness Prevention Act of 2019 Issues related to providing (during the COVID-19 emergency period) and preserving (after the COVID-19 emergency period) telehealth/telemedicine flexibilities for individuals with type 1 diabetes. Issues related to hospital inpatient blood glucose monitoring.
Client expense: $110,000 · Firm income: Not reported
2020 · second_quarter · Health Issues
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Technology research; Telemedicine and connected care; Remote patient monitoring; Implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).
Client expense: Not reported · Firm income: $70,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of
2020 · second_quarter · Medicare/Medicaid
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the COVID-19 health care issues issues within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); Telemedicine and connected care; Remote patient monitoring; Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); The implementation of the Medicare Access and CHIP reauthorization Act (H.R. 2); Safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).
Client expense: Not reported · Firm income: $70,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of
2020 · second_quarter · Medicare/Medicaid
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act 2020 (H.R. 6704) and the CARES Act (S. 3548/H.R. 748); Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the implementation of The Medicare Access and CHIP Reauthorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA Reform; Sepsis funding and education; Further Consolidated Appropriations Act of 2020 (H.R. 1865), Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R. 5254)
Client expense: $180,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of, White House Office
2020 · second_quarter · Health Issues
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act 2020 (H.R. 6704) and the CARES Act (S. 3548/H.R. 748); Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the implementation of The Medicare Access and CHIP Reauthorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA Reform; Sepsis funding and education; Further Consolidated Appropriations Act of 2020 (H.R. 1865), Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R. 5254)
Client expense: $180,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of, White House Office
2020 · second_quarter · Health Issues
H.R.3630, No Surprises Act of 2019. H.R.3762, Dental and Optometric Care Access Act. H.R.3975, Contact Lens Prescription Verification Modernization Act of 2019. H.R.5254, Diabetic Vision Loss and Blindness Prevention Act of 2019.
Client expense: $330,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Health Issues
Medicare coverage for medical technology. H.R. 5254, the Diabetic Vision Loss and Blindness Prevention Act.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Vice President of the U.S.
2020 · second_quarter · Medicare/Medicaid
Medicare coverage for medical technology. H.R. 5254, the Diabetic Vision Loss and Blindness Prevention Act.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Vice President of the U.S.
2020 · first_quarter · Health Issues
S. 1895 - Lower Health Care Costs Act H.R. 2668 - Special Diabetes Program Reauthorization Act of 2019 H.R. 2680 - Special Diabetes Program for Indians Reauthorization Act of 2019 H.R. 2328 - Reauthorizing and Extending Americas Community Health Act (REACH Act) H.R. 965 - CREATES Act of 2019 S. 2543 - The Prescription Drug Pricing Reduction Act of 2019 S. 2199, H.R. 4906 - Insulin Price Reduction Act S. 2004, H.R. 4010 -- Emergency Access to Insulin Act of 2019 H.R. 3 - Lower Drug Costs Now Act of 2019 S. 2855 - Insulin Affordability Data Collection Act H.R. 19, S. 3129 - Lower Costs, More Cures Act of 2019 Issues and legislation related to drug pricing, specifically as it relates to insulin Issues and legislation related to a passthrough of any/all savings to beneficiaries using insulin in Medicare Part D. Issues and legislation related to providing flexibility in the split of a deductible between devices and prescription drugs Issues related to the importance of preserving health insurance protections for individuals with pre-existing conditions. H.R. 5254 - Diabetic Vision Loss and Blindness Prevention Act of 2019 Issues relates to expanding telehealth under Medicare for the purposes of qualifying visits for insulin pumps and continuous glucose monitors. S. 3548, H.R. 748 - CARES Act
Client expense: $190,000 · Firm income: Not reported
2020 · first_quarter · Medicare/Medicaid
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the COVID-19 health care issues issues within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); Telemedicine and connected care; Remote patient monitoring; Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); The implementation of the Medicare Access and CHIP reauthorization Act (H.R. 2); Safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).
Client expense: Not reported · Firm income: $130,000
2020 · first_quarter · Health Issues
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Technology research; Telemedicine and connected care; Remote patient monitoring; Implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).
Client expense: Not reported · Firm income: $130,000
2020 · first_quarter · Health Issues
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act 2020 (H.R. 6704) and the CARES Act (S. 3548/H.R. 748); Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the implementation of The Medicare Access and CHIP Reauthorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA Reform; Sepsis funding and education; Further Consolidated Appropriations Act of 2020 (H.R. 1865), Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R. 5254)
Client expense: $250,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Vice President of the U.S., White House Office
2020 · first_quarter · Medicare/Medicaid
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act 2020 (H.R. 6704) and the CARES Act (S. 3548/H.R. 748); Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the implementation of The Medicare Access and CHIP Reauthorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA Reform; Sepsis funding and education; Further Consolidated Appropriations Act of 2020 (H.R. 1865), Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R. 5254)
Client expense: $250,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Vice President of the U.S., White House Office
2020 · first_quarter · Medicare/Medicaid
Medicare coverage for medical technology. H.R. 5254, the Diabetic Vision Loss and Blindness Prevention Act.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Vice President of the U.S.
2020 · first_quarter · Health Issues
Medicare coverage for medical technology. H.R. 5254, the Diabetic Vision Loss and Blindness Prevention Act.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Vice President of the U.S.
2020 · first_quarter · Health Issues
H.R.3, Elijah E. Cummings Lower Drug Costs Now Act. H.R.748,the CARES Act of 2020. H.R.3630, No Surprises Act of 2019. H.R.3762, Dental and Optometric Care Access Act. H.R.3975, Contact Lens Prescription Verification Modernization Act of 2019. H.R.5254, Diabetic Vision Loss and Blindness Prevention Act of 2019. H.R.6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020. H.R.6201, Families First Coronavirus Response Act of 2020. S.1895, Lower Health Care Costs Act of 2019.
Client expense: $430,000 · Firm income: Not reported
2019 · fourth_quarter · Health Issues
S. 1895 - Lower Health Care Costs Act H.R. 2668 - Special Diabetes Program Reauthorization Act of 2019 H.R. 2680 - Special Diabetes Program for Indians Reauthorization Act of 2019 H.R. 2328 - Reauthorizing and Extending Americas Community Health Act (REACH Act) H.R. 965 - CREATES Act of 2019 S. 2543 - The Prescription Drug Pricing Reduction Act of 2019 S. 2199, H.R. 4906 - Insulin Price Reduction Act S. 2004, H.R. 4010 -- Emergency Access to Insulin Act of 2019 H.R. 3 - Lower Drug Costs Now Act of 2019 S. 2855 - Insulin Affordability Data Collection Act H.R. 19, S. 3129 - Lower Costs, More Cures Act of 2019 Issues and legislation related to drug pricing, specifically as it relates to insulin Issues and legislation related to providing flexibility in the split of a deductible between devices and prescription drugs Issues related to the importance of preserving health insurance protections for individuals with pre-existing conditions. H.R. 5254 - Diabetic Vision Loss and Blindness Prevention Act of 2019
Client expense: $120,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Health Issues
Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the Protect Medical Innovation Act (S. 692, H.R. 2207); the implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); diabetic retinopathy; Bipartisan Budget Act of 2018; safe patient handling, FDA reform; Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 (H.R. 2740); Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).
Client expense: Not reported · Firm income: $130,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2019 · fourth_quarter · Medicare/Medicaid
Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); telemedicine and connected care; remote patient monitoring; Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); Protect Medical Innovation Act of 2019 (H.R. 2207/S. 692); the implementation of the Medicare Access and CHIP reauthorization Act (H.R. 2); safe patient handling, FDA reform; Extension of Continuing Appropriations Act of 2018. Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 (H.R. 2740); Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).
Client expense: Not reported · Firm income: $130,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2019 · fourth_quarter · Health Issues
Medicare coverage for medical technology. H.R. 5254, the Diabetic Vision Loss and Blindness Prevention Act.
Client expense: Not reported · Firm income: $50,000
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Medicare/Medicaid
Medicare coverage for medical technology. H.R. 5254, the Diabetic Vision Loss and Blindness Prevention Act.
Client expense: Not reported · Firm income: $50,000
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Health Issues
Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the Protect Medical Innovation Act (S. 692, H.R. 2207); the implementation of The Medicare Access and CHIP Reauthorization Act (H.R. 2); diabetic retinopathy; Bipartisan Budget Act of 2018; safe patient handling, FDA Reform; Labor Health and Human Services, Education, Defense, State, Foreign Operations and Energy and Water Development Appropriations Act, 2020 (H.R. 1865); Sepsis funding and education; Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R. 5254)
Client expense: $240,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2019 · fourth_quarter · Medicare/Medicaid
Technology research; telemedicine and connected care; remote patient monitoring; implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); the Protect Medical Innovation Act (S. 692, H.R. 2207); the implementation of The Medicare Access and CHIP Reauthorization Act (H.R. 2); diabetic retinopathy; Bipartisan Budget Act of 2018; safe patient handling, FDA Reform, Extension of Continuing Appropriations Act of 2020. Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 (HR 1865); Sepsis funding and education; and Diabetic Vision Loss and Blindness Prevention Act (H.R. 5254)
Client expense: $240,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2019 · fourth_quarter · Health Issues
H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act. H.R. 3630, No Surprises Act of 2019. H.R. 3762, Dental and Optometric Care Access Act. H.R.3975, Contact Lens Prescription Verification Modernization Act of 2019. H.R.5254 - Diabetic Vision Loss and Blindness Prevention Act of 2019 S. 1895 Lower Health Care Costs Act of 2019.. H.R.5254 - Diabetic Vision Loss and Blindness Prevention Act of 2019.
Client expense: $380,000 · Firm income: Not reported
| Democratic |
| TX |
| Tom Reed | Republican | NY |
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE